Natco Of India Launches Bone-Cancer Generic It Sees As Blockbuster
This article was originally published in PharmAsia News
Executive Summary
India's Natco Pharma has launched at home its generic of Treanda (bendamustine), U.S.-based Cephalon's drug to treat cancer of the soft tissue in bones